Janet Chou

Dr. Janet Chou is an Associate Professor of Pediatrics at Harvard Medical School and serves as Section Chief of Clinical Immunology and Director of the Immunogenomics Program at Boston Children's Hospital. Her clinical practice focuses on patients with allergic diseases and immunodeficiencies, and she serves as an expert for the hospital's Precision Medicine Service.

Dr. Chou's educational background includes undergraduate studies at Harvard University (1998), medical school at Harvard Medical School (2004), and clinical training at Boston Children's Hospital (internship 2005, residency 2007, fellowship in Allergy and Immunology 2010). She is board-certified by the American Board of Allergy & Immunology and the American Board of Pediatrics.

Dr. Chou's research focuses on the genetic and molecular mechanisms driving disorders of immune dysfunction. Her work spans primary immunodeficiencies, genetic susceptibility to immune disorders, and the immunological aspects of infectious diseases like COVID-19. She has made significant contributions to understanding the genetic basis of conditions such as CTLA-4 deficiency, DOCK8 deficiency, and multisystem inflammatory syndrome in children.

Analysis of Dr. Chou's recent publications reveals a strong focus on the genetic underpinnings of immune disorders, with particular emphasis on primary immunodeficiencies and their relationship to infectious disease susceptibility. Her work bridges clinical immunology with genomic approaches, demonstrating expertise in both patient care and cutting-edge research methodologies.

Dr. Chou's leadership roles as Section Chief of Clinical Immunology and Director of the Immunogenomics Program reflect her standing in the immunology field. She serves as an expert for Boston Children's Hospital Precision Medicine Service, applying genomic information to clinical care.

As Section Chief, Dr. Chou oversees clinical services for patients with immune disorders. She directs the Immunogenomics Program, which integrates genomic approaches with clinical immunology practice. Her work with the Precision Medicine Service demonstrates her commitment to applying advanced diagnostics and personalized treatment approaches for patients with complex immune disorders.